Ravuconazole雷夫康唑,182760-06-1

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Ravuconazole

CAS No. : 182760-06-1

MCE 国际站：Ravuconazole

产品活性：Ravuconazole (BMS-207147;ER-30346) 是一种口服的三唑抗真菌活性分子，能够有效广谱的抑制真菌。

研究领域：Anti-infection

作用靶点：Fungal

In Vitro: Ravuconazole shows a broad spectrum of activity against a wide range of fungi covering Candida spp., Trichosporon beigelii, C. neoformans and A. fumigatus. The MIC₉₀ ranges from 0.025 to 0.39 mg/mL.Ravuconazoleshows relatively higher levels of activity against three strains of Candida krusei, with MICs ranging from 0.05 to 0.39 mg/mL.Ravuconazoleshows good activity against T. mentagrophytes, T. rubrum, M. gypseum and M. caniswith MICs ranging from 0.05 to 0.39 mg/mL. Ravuconazoleis about two- to four fold more potent than itraconazole and about 40-fold more active than fluconazole against yeasts. Ravuconazoleand itraconazoleare inhibitory to most aspergilli, and against half of the isolates, the activity iscidal. Ravuconazoleand itraconazoleare active, though not cidal, against most hyaline Hyphomycetes, dermatophytes, and the dematiaceous fungi and inactive against Sporothrix schenckii and zygomycetes.

In Vivo: The maximum concentration of ravuconazole in plasma and the area under the concentration-time curve for ravuconazoleshow good linearity over a range of doses from 2 to 40 mg/kg of body weight. Ravuconazole at a dose of 2.5 mg/kg delays mortality significantly compared with the control treatment.Ravuconazole also shows a substantial therapeutic effect against systemic cryptococcosis. Ravuconazole reduces the numbers of CFU in the lungs significantly compared with the numbers of CFU in the lungs of the controls. In an experimental model of oral candidiasis in rats, ravuconazole reduces the numbers of CFU in oral swabs significantly compared with the numbers of CFU in oral swabs from the controls and is more effective than itraconazole and as effective as fluconazole..

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Antifungal Compound Library  |  Anti-COVID-19 Compound Library  |  Orally Active Compound Library  |  Ferrostatin-1  |  Rapamycin  |  Cycloheximide  |  Staurosporine  |  Resveratrol  |  Hygromycin B  |  Tunicamycin  |  Oligomycin  |  Camptothecin  |  Filipin complex  |  Amphotericin B  |  Calcimycin  |  Nystatin  |  Ketoconazole  |  Itraconazole  |  Tofacitinib citrate  |  Valinomycin  |  Fluconazole  |  Mycophenolic acid  |  Caspofungin diacetate  |  Toyocamycin  |  Leptomycin B  |  Idarubicin hydrochloride  |  Hyperoside  |  Saponins  |  Aureobasidin A  |  Terbinafine  |  Sinefungin  |  Carvacrol

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds